Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 21Insulin Resistance 5Obesity 4Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Menstruation Disturbances 2Medulloblastoma 2Infertility 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Toxemia 1Thyroid Neoplasms 1Premature Birth 1Pregnancy Complications 1Prediabetic State 1Pre-Eclampsia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasm Metastasis 1Mouth Neoplasms 1Metabolic Syndrome 1Liver Neoplasms 1Infertility, Female 1Hyperinsulinism 1Hyperandrogenism 1

Interventions

Exercise 9Metformin 2tislelizumab 1Vitamin D 1Tea 1Surveys and Questionnaires 1Sugars 1Resistance Training 1Probiotics 1Oxaliplatin 1Nutrition Assessment 1Leucovorin 1Fluorouracil 1Fish Oils 1Diet, Mediterranean 1Diet Therapy 1Diet 1Curcumin 1Counseling 1Capecitabine 1Caloric Restriction 1Andrographis paniculata extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Motor Activity × Metformin × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡